Cargando…

Prenatal muscle development in a mouse model for the secondary dystroglycanopathies

BACKGROUND: The defective glycosylation of α-dystroglycan is associated with a group of muscular dystrophies that are collectively referred to as the secondary dystroglycanopathies. Mutations in the gene encoding fukutin-related protein (FKRP) are one of the most common causes of secondary dystrogly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jihee, Hopkinson, Mark, Kavishwar, Manoli, Fernandez-Fuente, Marta, Brown, Susan Carol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759920/ https://www.ncbi.nlm.nih.gov/pubmed/26900448 http://dx.doi.org/10.1186/s13395-016-0073-y

Ejemplares similares

Retinal Proteomics of a Mouse Model of Dystroglycanopathies Reveals Molecular Alterations in Photoreceptors
por: Uribe, Mary Luz, et al.
Publicado: (2021)

A molecular overview of the primary dystroglycanopathies
por: Brancaccio, Andrea
Publicado: (2019)

Impairment of photoreceptor ribbon synapses in a novel Pomt1 conditional knockout mouse model of dystroglycanopathy
por: Rubio-Fernández, Marcos, et al.
Publicado: (2018)

NAD+ improves neuromuscular development in a zebrafish model of FKRP-associated dystroglycanopathy
por: Bailey, Erin C., et al.
Publicado: (2019)

Dystroglycanopathy: From Elucidation of Molecular and Pathological Mechanisms to Development of Treatment Methods
por: Kanagawa, Motoi
Publicado: (2021)

TMEM5-associated dystroglycanopathy presenting with CMD and mild limb-girdle muscle involvement
por: Astrea, Guja, et al.
Publicado: (2016)

Dystroglycan and dystroglycanopathies: Report of the 187th ENMC Workshop 11–13 November 2011, Naarden, The Netherlands
por: Brown, Susan C., et al.
Publicado: (2012)

Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy
por: Foltz, Steven J., et al.
Publicado: (2016)

A new patient‐derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α‐dystroglycan
por: Kim, Jihee, et al.
Publicado: (2019)

Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies
por: Belaya, Katsiaryna, et al.
Publicado: (2015)

Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies
por: Lin, Yung-Yao, et al.
Publicado: (2011)

Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation
por: Heywood, Wendy E., et al.
Publicado: (2016)

A translational approach to dystroglycanopathies: a frequent type of muscular dystrophy
por: Cirak, Sebahattin, et al.
Publicado: (2015)

LARGE expression in different types of muscular dystrophies other than dystroglycanopathy
por: Balci-Hayta, Burcu, et al.
Publicado: (2018)

Phenotype and Genotype Study of Chinese POMT2-Related α-Dystroglycanopathy
por: Chen, Xiao-Yu, et al.
Publicado: (2021)

Flow Cytometry for the Analysis of α-Dystroglycan Glycosylation in Fibroblasts from Patients with Dystroglycanopathies
por: Stevens, Elizabeth, et al.
Publicado: (2013)

Clinical and electrophysiological evaluation of myasthenic features in an alpha-dystroglycanopathy cohort (FKRP- predominant)
por: Gonzalez-Perez, Paloma, et al.
Publicado: (2020)

Contribution of Dysferlin Deficiency to Skeletal Muscle Pathology in Asymptomatic and Severe Dystroglycanopathy Models: Generation of a New Model for Fukuyama Congenital Muscular Dystrophy
por: Kanagawa, Motoi, et al.
Publicado: (2014)

Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy
por: Kanagawa, Motoi, et al.
Publicado: (2009)

Human embryoid bodies as a 3D tissue model of the extracellular matrix and α-dystroglycanopathies
por: Nickolls, Alec R., et al.
Publicado: (2020)

Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes
por: Haro, Carmen, et al.
Publicado: (2018)

Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in Dystroglycanopathy
por: Kanagawa, Motoi, et al.
Publicado: (2017)

A universal gene correction approach for FKRP-associated dystroglycanopathies to enable autologous cell therapy
por: Dhoke, Neha R., et al.
Publicado: (2021)

Abnormal Skeletal Muscle Regeneration plus Mild Alterations in Mature Fiber Type Specification in Fktn-Deficient Dystroglycanopathy Muscular Dystrophy Mice
por: Foltz, Steven J., et al.
Publicado: (2016)

Case Report: ISPD Gene Mutation Leads to Dystroglycanopathies: Genotypic Phenotype Analysis and Treatment Exploration
por: Yang, Haiyan, et al.
Publicado: (2021)

Novel mutations in B3GALNT2 gene causing α-dystroglycanopathy in Chinese patients
por: Chen, Xiao-Yu, et al.
Publicado: (2021)

Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness
por: Johnson, Katherine, et al.
Publicado: (2018)

Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study
por: Astrea, Guja, et al.
Publicado: (2018)

biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies
por: Gumlaw, Nathan, et al.
Publicado: (2020)

Ectopic clustering of Cajal–Retzius and subplate cells is an initial pathological feature in Pomgnt2-knockout mice, a model of dystroglycanopathy
por: Nakagawa, Naoki, et al.
Publicado: (2015)

The Structure of the T190M Mutant of Murine α-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy
por: Bozzi, Manuela, et al.
Publicado: (2015)

Mutations in INPP5K Cause a Form of Congenital Muscular Dystrophy Overlapping Marinesco-Sjögren Syndrome and Dystroglycanopathy
por: Osborn, Daniel P.S., et al.
Publicado: (2017)

Compound heterozygous POMT1 mutations in a Chinese family with autosomal recessive muscular dystrophy‐dystroglycanopathy C1
por: Hu, Pengzhi, et al.
Publicado: (2017)

Compound heterozygous POMGNT1 mutations leading to muscular dystrophy-dystroglycanopathy type A3: a case report
por: Borisovna, Kondakova Olga, et al.
Publicado: (2019)

A mutation in mannose‐phosphate‐dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy
por: van Tol, Walinka, et al.
Publicado: (2019)

A Child of Congenital Muscular Dystrophy-Dystroglycanopathy with Homozygous Missense Variation in Exon 3 of the ISPD Gene: A Rare Case from Odisha
por: Biswal, Sebaranjan, et al.
Publicado: (2020)

Dynamics of microRNA expression during mouse prenatal development
por: Rahmanian, Sorena, et al.
Publicado: (2019)

Quantification of Mouse Lung Elastin During Prenatal Development
por: Rodrigues, Paula, et al.
Publicado: (2008)

THE PRENATAL GROWTH OF THE MOUSE
por: MacDowell, E. C., et al.
Publicado: (1927)

Whole exome sequencing identified a novel DAG1 mutation in a patient with rare, mild and late age of onset muscular dystrophy‐dystroglycanopathy
por: Dai, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0qbgan4hs61kjeh6cp9nlf18h0